- Home
- NCI vs XXII Comparison
NCI vs XXII Comparison
Compare NCI & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCI
- XXII
- Stock Information
- Founded
- NCI 1992
- XXII 1998
- Country
- NCI Hong Kong
- XXII United States
- Employees
- NCI N/A
- XXII N/A
- Industry
- NCI
- XXII Medicinal Chemicals and Botanical Products
- Sector
- NCI
- XXII Health Care
- Exchange
- NCI NYSE
- XXII Nasdaq
- Market Cap
- NCI 7.4M
- XXII 7.0M
- IPO Year
- NCI 2024
- XXII N/A
- Fundamental
- Price
- NCI $2.06
- XXII $5.14
- Analyst Decision
- NCI
- XXII
- Analyst Count
- NCI 0
- XXII 0
- Target Price
- NCI N/A
- XXII N/A
- AVG Volume (30 Days)
- NCI 173.5K
- XXII 137.3K
- Earning Date
- NCI 07-22-2025
- XXII 08-12-2025
- Dividend Yield
- NCI N/A
- XXII N/A
- EPS Growth
- NCI 67.70
- XXII N/A
- EPS
- NCI 0.26
- XXII N/A
- Revenue
- NCI $30,340,230.00
- XXII $23,869,000.00
- Revenue This Year
- NCI N/A
- XXII $22.41
- Revenue Next Year
- NCI N/A
- XXII $76.35
- P/E Ratio
- NCI $7.74
- XXII N/A
- Revenue Growth
- NCI 35.28
- XXII N/A
- 52 Week Low
- NCI $1.40
- XXII $5.02
- 52 Week High
- NCI $9.00
- XXII $2,837.04
- Technical
- Relative Strength Index (RSI)
- NCI N/A
- XXII 21.82
- Support Level
- NCI N/A
- XXII $5.73
- Resistance Level
- NCI N/A
- XXII $6.98
- Average True Range (ATR)
- NCI 0.00
- XXII 0.89
- MACD
- NCI 0.00
- XXII 0.27
- Stochastic Oscillator
- NCI 0.00
- XXII 2.68
About NCI NEO-CONCEPT INTL GRP HLDGS LTD
Neo-Concept International Group Holdings Ltd is a company that is a one-stop apparel solution services provider. The company offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European and North American markets.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.